Literature DB >> 8018768

Symptomatic hereditary type-II protein C deficiency caused by a missense mutation in exon IX of the protein C gene (Gly381 to Ser).

E Wittmann1, J Walter, I Pabinger-Fasching, H H Watzke.   

Abstract

We report the characterization of the genetic defect in a family with hereditary type-II protein C (PC) deficiency. The propositus is a 28-year-old woman with a history of thrombosis. Her PC activity level (58%) and PC antigen level (115%) are compatible with the diagnosis of type-II PC deficiency. Her asymptomatic sister is also PC deficient. Analysis of the PC gene of the propositus revealed a point mutation (G to A) at nucleotide 8856, which results in the replacement of Gly381 by Ser in the heavy chain of PC. The amino acid change occurs close to the active-site serine at a residue which is highly conserved among the serine proteases. The mutation is also present in the PC gene of the propositus' sister. Her brother, who is asymptomatic, has a normal genotype with respect to the mutation at nucleotide 8856.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018768     DOI: 10.1007/bf01737427

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  31 in total

1.  Protein C deficiency in Austria.

Authors:  I Pabinger-Fasching; E Deutsch
Journal:  Semin Thromb Hemost       Date:  1985-10       Impact factor: 4.180

2.  Anticoagulant properties of bovine plasma protein C following activation by thrombin.

Authors:  W Kisiel; W M Canfield; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

3.  Evolution and organization of the human protein C gene.

Authors:  J Plutzky; J A Hoskins; G L Long; G R Crabtree
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

4.  Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.

Authors:  Y Sakata; S Curriden; D Lawrence; J H Griffin; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

Review 5.  The molecular basis of blood coagulation.

Authors:  B Furie; B C Furie
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

6.  Mutations in hemophilia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX.

Authors:  R M Bertina; I K van der Linden; P M Mannucci; H H Reinalda-Poot; R Cupers; S R Poort; P H Reitsma
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

Review 7.  Clinical relevance of protein C.

Authors:  I Pabinger
Journal:  Blut       Date:  1986-08

8.  DNA sequence analysis with a modified bacteriophage T7 DNA polymerase.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

9.  Proteolytic activation of protein C from bovine plasma.

Authors:  W Kisiel; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

10.  The clinical spectrum of heterozygous protein C deficiency in a large New England kindred.

Authors:  E G Bovill; K A Bauer; J D Dickerman; P Callas; B West
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

View more
  1 in total

1.  Comparison of biological activities of two low molecular weight heparins in 10 healthy volunteers.

Authors:  M Azizi; C Veyssier-Belot; M Alhenc-Gelas; G Chatellier; E Billaud-Mesguish; J N Fiessinger; M Aiach
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.